The DOI matches its Crossref record.
The c‐kit receptor ligand functions as a mast cell chemoattractant
Abstract
Mast cells accumulate at sites of neovascularization, solid tumors, and many immune reactions. Such accumulation requires directed migration of mature mast cells or their precursors. The nature of the chemoattractants that regulate mast cell motility and the identity of the receptors that mediate the chemotactic response are poorly understood. We have tested the ability of stem cell factor (SCF), a mast cell growth factor, to stimulate mast cell migration. Our results show that SCF is a potent mast cell attractant that stimulates directional motility of both mucosal and connective tissue-type mast cells. The activity is potentiated by costimulation with interleukin-3 (IL-3), another mast cell chemoattractant. SCF, a known ligand for the c-kit tyrosine kinase receptor, was unable to stimulate motility in W42 mutant mast cells, which have a defective c-kit tyrosine kinase. However, W42 mast cells were still able to migrate in response to IL-3. These results show that SCF is a chemotactic factor as well as a growth factor and that the c-kit receptor can transduce signals leading to both cell proliferation and increased directional cell motility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SCF is required for mast cell (progenitor) chemotaxis, 87 , 88 differentiation, adhesion, 89 , 90 proliferation, and survival by blocking apoptosis. 91 , 92 , 93”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 3
- Silvers W K White-spotting, patch and rump-white; steel, flexed tail, plotch and variant waddler, in The Coat Colors of Mice: A Model for Gene Action and Interaction. New York, JVY, Springer-Verlag, 1979, p 206
- Kitamura Y, Go S: Decreased production of mast cells in SIISl" anemic mice. Blood 53:492,1979 18. Russell ES: Hereditary anemias of the mouse: A review for geneticists. Adv Genet 20:357, 1979
- Marshall JS, Bienenstock J: Mast Cells. Springer Semin Immunopathol 12:191,1990
Cited by
Sorted by citations
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT
Dubreuil, P., Letard, S., Ciufolini, M., Gros, L., Humbert, M., Castéran, N., Borge, L., Hajem, B., Lermet, A., Sippl, W., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007258 · Cited by 421
Mast-cell responses in the development of asthma
Bingham, C. O., & Austen, K. F. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90056-3 · Cited by 80
Mast cell ontogeny: From fetal development to life‐long health and disease
Chia, S. L., Kapoor, S., Carvalho, C., Bajénoff, M., & Gentek, R. (2023) · Immunological Reviews · doi:10.1111/imr.13191 · Cited by 60
Sprinzl, B., Greiner, G., Uyanik, G., Arock, M., Haferlach, T., Sperr, W. R., Valent, P., & Hoermann, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052458 · Cited by 51
Metadata
- Authors
- Meininger, C., Yano, H., Rottapel, R., Bernstein, A., Zsebo, K., & Zetter, B.
- Affiliations
- Department of Surgery, Harvard Medical School, Children's Hospital, Boston, MA 02115.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1992-02-15
- Volume
- 79
- Issue
- 4
- Pages
- 958-963
- ISSN
- 0006-4971
- 1528-0020
- Cited by
- 10
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The c‐kit receptor ligand functions as a mast cell chemoattractant. https://app.cochat.ai/papers/10.1182/blood.v79.4.958.958
- The paper
- Meininger, C., Yano, H., Rottapel, R., Bernstein, A., Zsebo, K., & Zetter, B. (1992). The c‐kit receptor ligand functions as a mast cell chemoattractant. Blood. https://doi.org/10.1182/blood.v79.4.958.958